<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(1)</volume><submitter>Liu M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Bladder cancer (BCa) is the most prevalent malignancy of the urinary system. Aberrant glycosylation, driven by specific glycosyltransferases (GTs), plays a pivotal role in various carcinogenic processes. However, the role of GTs-related glycobiomarkers and their underlying mechanisms in BCa remain poorly understood.&lt;h4>Methods&lt;/h4>A diagnostic model based on GTs was constructed and validated using multiple bioinformatics tools. The diagnostic and prognostic value, biological functions and potential targeted drugs were assessed using R packages, K-M plotter and molecular docking. The functional impact and mechanism of ALG3 in BCa were investigated through functional assays, RNA sequencing, immunoprecipitation, and lectin pull down assays.&lt;h4>Results&lt;/h4>A diagnostic model</pubmed_abstract><journal>European journal of medical research</journal><pagination>353</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12046919</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>ɑ1,3-mannosyltransferase promotes the malignant progression of bladder cancer through activating TNF signaling pathway.</pubmed_title><pmcid>PMC12046919</pmcid><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Liu M</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Jiang W</pubmed_authors><pubmed_authors>Zheng Q</pubmed_authors><pubmed_authors>Yan Y</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>ɑ1,3-mannosyltransferase promotes the malignant progression of bladder cancer through activating TNF signaling pathway.</name><description>&lt;h4>Background&lt;/h4>Bladder cancer (BCa) is the most prevalent malignancy of the urinary system. Aberrant glycosylation, driven by specific glycosyltransferases (GTs), plays a pivotal role in various carcinogenic processes. However, the role of GTs-related glycobiomarkers and their underlying mechanisms in BCa remain poorly understood.&lt;h4>Methods&lt;/h4>A diagnostic model based on GTs was constructed and validated using multiple bioinformatics tools. The diagnostic and prognostic value, biological functions and potential targeted drugs were assessed using R packages, K-M plotter and molecular docking. The functional impact and mechanism of ALG3 in BCa were investigated through functional assays, RNA sequencing, immunoprecipitation, and lectin pull down assays.&lt;h4>Results&lt;/h4>A diagnostic model</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-05-25T03:09:50.986Z</modification><creation>2025-07-08T03:13:44.413Z</creation></dates><accession>S-EPMC12046919</accession><cross_references><pubmed>40312703</pubmed><doi>10.1186/s40001-025-02604-5</doi></cross_references></HashMap>